- Home
- Publications
- Publication Search
- Publication Details
Title
The curcumin analog DM-1 induces apoptotic cell death in melanoma
Authors
Keywords
Melanoma, Dacarbazine (DTIC), DM-1, Curcumin analog, Apoptosis, Synergism
Journal
TUMOR BIOLOGY
Volume 34, Issue 2, Pages 1119-1129
Publisher
Springer Nature
Online
2013-01-28
DOI
10.1007/s13277-013-0653-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Advances in the management of melanoma: targeted therapy, immunotherapy and future directions
- (2012) Emma Dean et al. Expert Review of Anticancer Therapy
- Medikamentöse Therapie des malignen Melanoms
- (2012) B.M. Rudolph et al. HAUTARZT
- Anti-tumor and pro-apoptotic activity of ethanolic extract and its various fractions from Polytrichum commune L.ex Hedw in L1210 cells
- (2012) Xiaoxia Cheng et al. JOURNAL OF ETHNOPHARMACOLOGY
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Proteasome inhibition and ROS generation by 4-nerolidylcatechol induces melanoma cell death
- (2012) Carla A. Brohem et al. Pigment Cell & Melanoma Research
- [DLys6]-luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo
- (2011) S. Aggarwal et al. INTERNATIONAL JOURNAL OF CANCER
- Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1
- (2011) Abdurazzag Abusnina et al. MOLECULAR NUTRITION & FOOD RESEARCH
- DM-1, sodium 4-[5-(4-hydroxy-3-methoxyphenyl)-3-oxo-penta-1,4-dienyl]-2-methoxy-phenolate: a curcumin analog with a synergic effect in combination with paclitaxel in breast cancer treatment
- (2011) Fernanda Faião-Flores et al. TUMOR BIOLOGY
- New antitumoral agents I: In vitro anticancer activity and in vivo acute toxicity of synthetic 1,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadien-3-one and derivatives
- (2010) José Agustín Quincoces Suarez et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
- (2010) Rita G Ladstein et al. BMC CANCER
- PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells
- (2010) Ensaf M. Al-Hujaily et al. BREAST CANCER RESEARCH AND TREATMENT
- Effect of Curcuma zedoaria crude extract against tumor progression and immunomodulation
- (2010) FR Carvalho et al. JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES
- The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity
- (2010) Matthew A Bill et al. Molecular Cancer
- Mitochondria and cell death: outer membrane permeabilization and beyond
- (2010) Stephen W. G. Tait et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Methoxy- and Fluoro-chalcone Derivatives Arrest Cell Cycle Progression and Induce Apoptosis in Human Melanoma Cell A375
- (2009) Kayo Henmi et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Chemotherapy and biologic therapies for melanoma: do they work?
- (2009) Lucia B. Jilaveanu et al. CLINICS IN DERMATOLOGY
- Pharmacological actions of curcumin in liver diseases or damage
- (2009) Yadira Rivera-Espinoza et al. LIVER INTERNATIONAL
- TRAILing death in cancer
- (2009) Gregory Mellier et al. MOLECULAR ASPECTS OF MEDICINE
- Effect of curcumin analog on γ-radiation-induced cellular changes in primary culture of isolated rat hepatocytes in vitro
- (2008) M. Srinivasan et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Melanoma epidemiology and trends
- (2008) Claus Garbe et al. CLINICS IN DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started